Why the study?
Unique pathophysiologic considerations of severe tricuspid regurgitation have prompted advancements in surgical and transcatheter treatments, motivating a review of current interventions for functional disease.
Do surgical and transcatheter tricuspid valve interventions improve outcomes in patients with severe tricuspid regurgitation and heart failure?
Design
Review
Key result
Transcatheter edge-to-edge repair and replacement improve quality of life compared to medical therapy for high-surgical-risk patients with severe symptomatic tricuspid regurgitation.
Authors
Loading...
Ring annuloplasty may yield better surgical outcomes than replacement for functional TR; leaves open optimal patient selection and TTVI integration.
Do surgical and transcatheter tricuspid valve interventions improve outcomes in patients with severe tricuspid regurgitation and heart failure?
Transcatheter tricuspid valve interventions provide a crucial treatment option that improves quality of life for high-surgical-risk patients with severe tricuspid regurgitation, addressing a gap left by high-risk surgical options.
Chen et al. (2023) conducted a review in Severe tricuspid regurgitation (TR) in patients with heart failure. Surgical and transcatheter tricuspid valve interventions (TTVI) vs. Medical therapy alone was evaluated. Transcatheter edge-to-edge repair and replacement improve quality of life compared to medical therapy for high-surgical-risk patients with severe symptomatic tricuspid regurgitation.